CL vs CSTL · P/E 34, rev $10.69B vs rev $187.2M
Colgate-Palmolive Company (CL) versus Castle Biosciences Inc (CSTL) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Castle Biosciences Inc (CSTL) is a diagnostics & research company listed on US.
Latest reported CL revenue for 2026-06-30 was $10.69B. Net income was $1.34B. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported CSTL revenue for 2026-06-30 was $187.2M. Net income was -$16.6M. CSTL currently screens at market cap $570.2M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. CSTL currently screens at market cap $570.2M.
Not investment advice. Open the CL and CSTL stock pages for the full models.
Not investment advice.